Placental protein 13 (PP13)-induced vasodilation of resistance arteries from pregnant and nonpregnant rats occurs via endothelial-signaling pathways

References

• Than NG, Romero R, Goodman M, et al. A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death. Proc Natl Acad Sci USA 2009;106(24):9731–6.
   PubMed Web of Science ®Google Scholar
• Huppertz B, Meiri H, Gizurarson S, et al. Placental protein 13 (PP13): A new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia. Hum Reprod Update 2013;19(4):391–405.
   PubMed Web of Science ®Google Scholar
• Huppertz B, Sammar M, Chefetz I, et al. Longitudinal determination of serum placental protein 13 during development of preeclampsia. Fetal Diagn Ther 2008;24(3):230–6.
   PubMed Web of Science ®Google Scholar
• Gizurarson S, Huppertz B, Osol G, et al. Effects of placental protein 13 on the cardiovascular system in gravid and non-gravid rodents. Fetal Diagn Ther 2013;33(4):257–264.
   PubMed Web of Science ®Google Scholar
• Gizurarson S, Sigurdardottir ER, Meiri H, et al. Placental protein 13 administration to pregnant rats lowers blood pressure and augments fetal growth and venous remodeling. Fetal Diagn Ther 2015;39(1):56–63
   PubMed Web of Science ®Google Scholar
• National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. 2011, National Academies Press (US): Washington (DC).
   Google Scholar
• Gokina NI, Kuzina OY, Vance AM. Augmented EDHF signaling in rat uteroplacental vasculature during late pregnancy. Am J Physiol Heart Circ Physiol 2010;299(5):H1642–52.
   PubMed Web of Science ®Google Scholar
• Colton I, Mandalá M, Morton J, et al. Influence of constriction, wall tension, smooth muscle activation and cellular deformation on rat resistance artery vasodilator reactivity. Cell Physiol Biochem 2012;29(5–6):883–92.
   PubMed Web of Science ®Google Scholar
• Jones CW, Mandala M, Barron C, et al. Mechanisms underlying maternal venous adaptation in pregnancy. Reprod Sci 2009;16(6):596–604.
   PubMed Web of Science ®Google Scholar
• Jones RL, Wise H, Clark R, et al. Investigation of the prostacyclin (IP) receptor antagonist RO1138452 on isolated blood vessel and platelet preparations. Br J Pharmacol 2006;149(1):110–20.
   PubMed Web of Science ®Google Scholar
• Burger O, Pick E, Zwickel J, et al. Placental protein 13 (PP-13): Effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. Placenta 2004;25(7):608–622.
   PubMed Web of Science ®Google Scholar
• Than NG Romero R, Meiri H, et al. PP13, maternal ABO blood groups and the risk assessment of pregnancy complications. PLoS One 2011;6(7):e21564.
   PubMed Web of Science ®Google Scholar
• Balogh A, Pozsgay J, Matkó J, et al. Placental protein 13 (PP13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome. Am J Obstet Gynecol 2011;205(2):156e1–14.
   Web of Science ®Google Scholar
• Gokina NI, Goecks T. Upregulation of endothelial cell Ca2+ signaling contributes to pregnancy-enhanced vasodilation of rat uteroplacental arteries. Am J Physiol Heart Circ Physiol 2006;290(5):H2124–35.
   PubMed Web of Science ®Google Scholar
• Takahashi A, Camacho P, Lechleiter JD, Herman B. Measurement of intracellular calcium. Physiol Rev 1999;79(4):1089–125.
   PubMed Web of Science ®Google Scholar
• Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260(6):3440–50.
   PubMed Web of Science ®Google Scholar
• Knot HJ, Nelson MT. Regulation of arterial diameter and wall [Ca2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol 1998;508 (Pt 1):199–209.
   PubMed Web of Science ®Google Scholar
• Sammar M, Nisamblatt S, Gonen R, et al. The role of the carbohydrate recognition domain of placental protein 13 (PP13) in pregnancy evaluated with recombinant PP13 and the DelT(221) PP13 variant. Plos One 2014;9(7):e102832.
   PubMed Web of Science ®Google Scholar
• Osol G, Mandala M. Maternal uterine vascular remodeling during pregnancy. Physiology (Bethesda) 2009;24:58–71.
   PubMed Web of Science ®Google Scholar
• Mandala M, Osol G. Physiological remodelling of the maternal uterine circulation during pregnancy. Basic Clin Pharmacol Toxico 2012;110(1):12–8.
   PubMed Web of Science ®Google Scholar
• Poon LC, Nicolaides KH. Early prediction of preeclampsia. Obstet Gynecol Int 2014;2014:297397;1–11.
   PubMedGoogle Scholar
• Poon LCY, Kametas NA, Maiz N, et al. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009;53(5):812–8.
   PubMed Web of Science ®Google Scholar
• Conrad KP, Joffe GM, Kruszyna HA, et al. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993;7(6):566–71.
   PubMed Web of Science ®Google Scholar
• Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol Reg Integ Comp Physiol 1997;272(2):R441–63.
   Web of Science ®Google Scholar
• Gizurarson S, Huppertz B, Osol G, et al. Effects of placental protein 13 on the cardiovascular system in gravid and non-gravid rodents. Fetal Diagn Ther 2013;33(4):257–64.
   PubMed Web of Science ®Google Scholar
• Than NG, Sumegi B, Than GN, et al. Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot-Leyden crystal protein. Placenta 1999;20(8):703–10.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Sngelaki A, Beta J, et al. Maternal serum placental protein 13 at 11–13 weeks of gestation in preeclampsia. Prenat Diagn 2009;29(12):1103–8.
   PubMed Web of Science ®Google Scholar
• Chafetz I, Kuhnreich I, Sammar M, et al. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2007;197(1):35 e1–7.
   Web of Science ®Google Scholar
• Odibo AO, Zhong Y, Goetzinger KR, et al. First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia. Placenta 2011;32(8):598–602.
   PubMed Web of Science ®Google Scholar
• Spencer K., Cowans NJ, Chefetz I, et al. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol 2007;29(2):128–34.
   PubMed Web of Science ®Google Scholar
• Lie RT, Rasmussen S, Brunborg H, et al. Fetal and maternal contributions to risk of pre-eclampsia: Population based study. BMJ 1998;316(7141):1343–7.
   PubMed Web of Science ®Google Scholar
• Kliman HJ, Sammar M, Grimpel YI, et al. Placental protein 13 and decidual zones of necrosis: An immunologic diversion that may be linked to preeclampsia. Reprod Sci 2012;19(1):16–30.
   PubMed Web of Science ®Google Scholar
• Than NG, Romero R, Meiri H, et al. PP13, maternal ABO blood groups and the risk assessment of pregnancy complications. PLoS One 2011;6(7):e21564.
   PubMed Web of Science ®Google Scholar
• Than NG, Balogh A, Romero R, et al. Placental protein 13 (PP13): A placental immunoregulatory galectin protecting pregnancy. Front Immunol 2014;5:348, 1–25.
   PubMed Web of Science ®Google Scholar
• Baxter GS, Clayton JK, Coleman RA, et al. Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery. Br J Pharmacol 1995;116(1):1692–6.
   PubMed Web of Science ®Google Scholar
• Coleman RA, Grix SP, Head SA, et al. A novel inhibitory prostanoid receptor in piglet saphenous vein. Prostaglandins 1994;47(2):151–68.
   PubMed Web of Science ®Google Scholar
• Rubanyi GM, Vanhoutte PM. Calcium and activation of the release of endothelium-derived relaxing factor. Ann N Y Acad Sci 1988;522:226–33.
   Web of Science ®Google Scholar
• Than NG, Pick E, Bellyei S, et al. Functional analyses of placental protein 13/galectin-13. Eur J Biochem 2004;271(6):1065–78.
   PubMedGoogle Scholar
• Yamashita M, Tsuji S, Nishiyama A, et al. Differential subcellular localization of COX-2 in macrophages phagocytosing heat-killed Mycobacterium bovis BCG. Am J Physiol Cell Physiol 2007;293(1):C184–90.
   PubMed Web of Science ®Google Scholar
• Fulton D, Gratton JP, Sessa WC. Post-translational control of endothelial nitric oxide synthase: Why isn’t calcium/calmodulin enough? J Pharmacol Exp Ther 2001;299(3):818–24.
   PubMed Web of Science ®Google Scholar
• Hernandez JD, Baum LG. Ah, sweet mystery of death! Galectins and control of cell fate. Glycobiology 2002;12(10):127R–36R.
   PubMed Web of Science ®Google Scholar